Zydus Lifesciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
885.00 +0.15 (0.02%)Updated : 23 Jan 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net 2,406.20-391.50-3,143.90-385.00
Net Changein Cash 413.80-74.80-170.002,372.90
Cash Taxes Paid 1,801.901,285.80592.00674.60
Net Income/ Starting Line 6,026.704,808.902,589.702,838.10
Total Cash Dividends Paid -302.50-621.00-267.10-372.20
Changesin Working Capital -391.70-2,270.80-1,139.90-1,333.30
Cashfrom Operating Activities 6,793.303,202.302,688.802,078.20
Cashfrom Financing Activities 2,014.20-1,778.80-4,400.40-868.30
Issuance( Retirement)of Stock Net 0.00-725.00-863.20-
Depreciation/ Depletion 915.80764.10722.70736.10
Other Investing Cash Flow Items Total -6,659.70-568.602,565.902,357.00
Capital Expenditures -1,712.60-906.60-1,030.90-1,202.60
period Type ----
Foreign Exchange Effects -21.40-23.106.608.60
Non- Cash Items 242.50-99.90516.30-162.70
Financing Cash Flow Items -89.50-41.30-126.20-111.10
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -8,372.30-1,475.201,535.001,154.40
*All figures in crores except per share values
Recommended For You
Trending Stocks
189.20+4.85(2.63%)
276.50-6.90 (-2.43%)
4,024.00-56.20 (-1.38%)